SG Americas Securities, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 84 filers reported holding ANTARES PHARMA INC in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$225,000
-35.3%
54,887
-43.7%
0.00%0.0%
Q4 2021$348,000
-30.4%
97,525
-29.0%
0.00%0.0%
Q3 2021$500,000
+50.2%
137,318
+79.9%
0.00%0.0%
Q2 2021$333,000
+187.1%
76,330
+169.5%
0.00%
+100.0%
Q1 2021$116,000
+118.9%
28,320
+114.6%
0.00%
Q4 2020$53,000
-81.5%
13,199
-87.6%
0.00%
-100.0%
Q3 2020$286,000
-64.7%
106,071
-64.0%
0.00%
-71.4%
Q2 2020$811,000
+144.3%
294,869
+109.4%
0.01%
+133.3%
Q1 2020$332,000
+264.8%
140,820
+628.2%
0.00%
+200.0%
Q4 2019$91,000
+23.0%
19,339
-12.7%
0.00%0.0%
Q3 2019$74,000
-43.9%
22,155
-44.6%
0.00%0.0%
Q2 2019$132,000
+85.9%
39,998
+70.5%
0.00%0.0%
Q1 2019$71,000
-45.8%
23,453
-51.3%
0.00%0.0%
Q4 2018$131,000
+385.2%
48,186
+299.8%
0.00%
Q1 2018$27,000
-66.2%
12,052
-70.2%
0.00%
-100.0%
Q4 2017$80,000
+100.0%
40,450
+231.5%
0.00%
Q3 2017$40,0000.0%12,203
-13.4%
0.00%
Q1 2017$40,000
-55.6%
14,096
-86.3%
0.00%
-100.0%
Q1 2016$90,000
-12.6%
103,113
+83.4%
0.00%0.0%
Q3 2014$103,000
+83.9%
56,231
+254.0%
0.00%
Q1 2014$56,000
-27.3%
15,884
-16.3%
0.00%
Q3 2013$77,00018,9720.00%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2013
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,055,0004.58%
Centric Wealth Management 3,337,449$13,717,0003.92%
Sargent Investment Group, LLC 3,599,580$14,794,0003.90%
Rubric Capital Management LP 8,722,647$35,850,0002.09%
PERKINS CAPITAL MANAGEMENT INC 542,283$2,229,0001.29%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$7,809,0001.17%
Venator Capital Management Ltd. 550,000$2,624,0000.89%
LEVEL FOUR FINANCIAL, LLC 120,000$493,0000.23%
ALGERT GLOBAL LLC 147,616$607,0000.19%
Brown Advisory Securities, LLC 275,000$1,130,0000.19%
View complete list of ANTARES PHARMA INC shareholders